Alteration of E2F2 Expression in Governing Endothelial Cell Senescence.


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
24 08 2022
Historique:
received: 23 07 2022
revised: 16 08 2022
accepted: 23 08 2022
entrez: 23 9 2022
pubmed: 24 9 2022
medline: 28 9 2022
Statut: epublish

Résumé

Endothelial cell senescence has a vital implication for vascular dysfunction, leading to age-related cardiovascular disease, especially hypertension and atherosclerosis. E2F transcription factor 2 (E2F2) plays a critical role in cell proliferation, differentiation, and DNA damage response. Up to date, no study has ever connected E2F2 to vascular endothelial cell senescence. Here, we demonstrate that E2F2 is involved in endothelial cellular senescence. We found that E2F2 expression is decreased during the replicative senescence of human umbilical vein endothelial cells (HUVECs) and the aortas of aged mice. The knockdown of

Identifiants

pubmed: 36140689
pii: genes13091522
doi: 10.3390/genes13091522
pmc: PMC9498592
pii:
doi:

Substances chimiques

E2F2 Transcription Factor 0
E2F2 protein, human 0
Interleukin-6 0
Interleukin-8 0
Nitric Oxide Synthase Type III EC 1.14.13.39
beta-Galactosidase EC 3.2.1.23
Sirtuin 1 EC 3.5.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Cancer Res. 1996 Oct 15;56(20):4582-5
pubmed: 8840965
Am J Physiol Gastrointest Liver Physiol. 2011 Jul;301(1):G20-31
pubmed: 21527726
Cell. 2013 Jun 6;153(6):1194-217
pubmed: 23746838
Biomed Res Int. 2021 Mar 30;2021:8098130
pubmed: 33860054
Exp Gerontol. 2019 May;119:212-220
pubmed: 30776409
Elife. 2016 Jan 14;5:e12994
pubmed: 26765561
J Atheroscler Thromb. 2010 May;17(5):431-5
pubmed: 20215708
Curr Biol. 1999 Sep 9;9(17):939-45
pubmed: 10508581
Mol Cell Proteomics. 2010 Oct;9(10):2184-94
pubmed: 20573986
Genes (Basel). 2022 Apr 18;13(4):
pubmed: 35456517
BMC Musculoskelet Disord. 2018 Sep 15;19(1):334
pubmed: 30219053
Cell Death Dis. 2019 Feb 4;10(2):105
pubmed: 30718471
Cardiovasc Res. 2008 Nov 1;80(2):219-26
pubmed: 18628254
Ageing Res Rev. 2016 Mar;26:96-111
pubmed: 26835847
Int J Mol Sci. 2021 May 07;22(9):
pubmed: 34067074
Int J Mol Sci. 2019 Sep 07;20(18):
pubmed: 31500313
Hypertens Res. 2012 Nov;35(11):1039-47
pubmed: 22972557
Trends Cell Biol. 2018 Jun;28(6):436-453
pubmed: 29477613
Mol Carcinog. 2010 Feb;49(2):152-6
pubmed: 19798698
Nature. 2001 Nov 22;414(6862):457-62
pubmed: 11719808
Cell. 2014 Nov 6;159(4):709-13
pubmed: 25417146
Mol Cell Biol. 2000 Sep;20(18):6741-54
pubmed: 10958672
Thromb Res. 2016 Nov;147:36-45
pubmed: 27669126
J Genet Genomics. 2014 Sep 20;41(9):485-95
pubmed: 25269674
Circulation. 2009 Sep 29;120(13):1213-21
pubmed: 19752322
Microcirculation. 2019 Feb;26(2):e12487
pubmed: 29924435
Cell Cycle. 2008 Dec 15;7(24):3915-27
pubmed: 19066456
Gene. 2007 Nov 1;402(1-2):103-10
pubmed: 17825503
Genes Dev. 2020 Dec 1;34(23-24):1565-1576
pubmed: 33262144
J Immunol. 1998 Nov 15;161(10):5203-9
pubmed: 9820491
Exp Gerontol. 2010 Oct;45(10):779-87
pubmed: 20600781
Int J Mol Sci. 2016 May 18;17(5):
pubmed: 27213333
Circulation. 2012 Jul 24;126(4):468-78
pubmed: 22705887
J Mol Cell Cardiol. 2015 Jun;83:112-21
pubmed: 25896391
Sci Rep. 2020 Oct 21;10(1):17948
pubmed: 33087787
Exp Gerontol. 2020 Jan;129:110750
pubmed: 31678465
Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9363-7
pubmed: 7568133
Front Cell Dev Biol. 2021 Mar 29;9:645593
pubmed: 33855023
Ageing Res Rev. 2016 Aug;29:1-12
pubmed: 27212009
Exp Gerontol. 2001 Aug;36(8):1327-47
pubmed: 11602208
Mol Cell Biol. 1993 Dec;13(12):7802-12
pubmed: 8246995
Exp Gerontol. 2003 Nov-Dec;38(11-12):1251-7
pubmed: 14698804
Aging Cell. 2021 Apr;20(4):e13338
pubmed: 33711211
Cell Syst. 2015 Sep 23;1(3):180-6
pubmed: 27135911
Leukemia. 2010 Apr;24(4):679-86
pubmed: 20130602
Cell Cycle. 2015;14(8):1300-14
pubmed: 25892555
Cancers (Basel). 2021 Mar 24;13(7):
pubmed: 33804958
Biol Pharm Bull. 2019;42(4):531-537
pubmed: 30930412
Heart Fail Clin. 2019 Oct;15(4):477-485
pubmed: 31472883
Oxid Med Cell Longev. 2018 Jul 18;2018:7671850
pubmed: 30116492
Biosci Trends. 2021 May 11;15(2):83-92
pubmed: 33952804

Auteurs

Hongfei Liu (H)

Vascular Function Laboratory, Human Aging Research Institute and School of Life Science, Jiangxi Key Laboratory of Human Aging, Nanchang University, Nanchang 330031, China.

Liping Chen (L)

Vascular Function Laboratory, Human Aging Research Institute and School of Life Science, Jiangxi Key Laboratory of Human Aging, Nanchang University, Nanchang 330031, China.

Wanli Xiao (W)

Metabolic Control and Aging, Human Aging Research Institute and School of Life Science, Jiangxi Key Laboratory of Human Aging, Nanchang University, Nanchang 330031, China.

Jiankun Liu (J)

Aging and Vascular Diseases, Human Aging Research Institute and School of Life Science, Jiangxi Key Laboratory of Human Aging, Nanchang University, Nanchang 330031, China.

Changkun Long (C)

Vascular Function Laboratory, Human Aging Research Institute and School of Life Science, Jiangxi Key Laboratory of Human Aging, Nanchang University, Nanchang 330031, China.

Wenxing Zhan (W)

Vascular Function Laboratory, Human Aging Research Institute and School of Life Science, Jiangxi Key Laboratory of Human Aging, Nanchang University, Nanchang 330031, China.

Cui Cui (C)

Department of Ophthalmology, Handan Central Hospital, Handan 056001, China.

Lin Yang (L)

Department of Nephrology, Taikang Southwestern Medical Center, Chengdu 610213, China.

Shenghan Chen (S)

Vascular Function Laboratory, Human Aging Research Institute and School of Life Science, Jiangxi Key Laboratory of Human Aging, Nanchang University, Nanchang 330031, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH